Bpifa6 Inhibitors
Bpifa6 inhibitors are a class of chemical compounds designed to interfere with the activity of the Bpifa6 protein, a member of the BPI fold-containing (BPIF) family of proteins. Bpifa6, like other BPIF proteins, is believed to play a role in innate immunity and the regulation of surface fluid layers, particularly in mucosal tissues. The precise biological functions of Bpifa6 remain under investigation, but its involvement in modulating protein-protein interactions, cellular signaling, and host defense mechanisms is of significant interest. By inhibiting Bpifa6, researchers aim to explore its function in various biological processes, including its potential role in maintaining homeostasis within mucosal environments.
Bpifa6 inhibitors are small molecules that interact with the active sites or binding domains of the Bpifa6 protein. These inhibitors can disrupt the normal functioning of Bpifa6 by preventing its interaction with other molecules or its ability to participate in signaling pathways. The chemical structures of Bpifa6 inhibitors often include functional groups that enhance specificity and binding affinity for the protein, allowing for selective inhibition. Through the use of Bpifa6 inhibitors, scientists can better understand the molecular pathways regulated by Bpifa6 and its influence on physiological processes such as immune responses, fluid regulation, and protein secretion. This class of inhibitors offers a valuable tool for probing the specific roles of Bpifa6 in various cellular contexts, ultimately contributing to a deeper understanding of the protein's biological significance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor affecting the JAK/STAT pathway, indirectly influencing Bpifa6. Suppresses JAK2 activation, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the JAK/STAT pathway. | ||||||
AZD1480 | 935666-88-9 | sc-364735 sc-364735A | 5 mg 50 mg | $124.00 $1072.00 | 11 | |
JAK inhibitor targeting JAK1/2, indirectly impacting Bpifa6 through the JAK/STAT pathway. Inhibits JAK phosphorylation, disrupting downstream signaling and altering the cellular environment that regulates Bpifa6 expression indirectly. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI3K/mTOR dual inhibitor disrupting the PI3K/AKT/mTOR pathway, indirectly affecting Bpifa6. Suppresses PI3K and mTOR activities, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the PI3K/AKT/mTOR pathway. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | $207.00 $515.00 | 6 | |
JAK2 inhibitor affecting the JAK/STAT pathway, indirectly influencing Bpifa6. Suppresses JAK2 activation, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the JAK/STAT pathway. | ||||||
A66 | 1166227-08-2 | sc-364394 sc-364394A | 5 mg 50 mg | $255.00 $1455.00 | ||
AKT inhibitor disrupting the PI3K/AKT pathway, indirectly affecting Bpifa6. Inhibits AKT phosphorylation, impacting downstream signaling and altering the cellular environment that regulates Bpifa6 expression indirectly through the PI3K/AKT pathway. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT inhibitor targeting all AKT isoforms, indirectly impacting Bpifa6 through the PI3K/AKT pathway. Suppresses AKT phosphorylation, disrupting downstream signaling and altering the cellular environment that regulates Bpifa6 expression indirectly. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK1/2 inhibitor affecting the JAK/STAT pathway, indirectly influencing Bpifa6. Suppresses JAK1/2 activation, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the JAK/STAT pathway. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $176.00 $235.00 $281.00 $339.00 | 9 | |
PI3K inhibitor disrupting the PI3K/AKT pathway, indirectly affecting Bpifa6. Inhibits PI3K activity, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the PI3K/AKT pathway. | ||||||
Cyt387 | 1056634-68-4 | sc-364733 sc-364733A | 10 mg 50 mg | $214.00 $612.00 | 2 | |
JAK1/2 inhibitor affecting the JAK/STAT pathway, indirectly influencing Bpifa6. Suppresses JAK1/2 activation, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the JAK/STAT pathway. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
PI3K/mTOR dual inhibitor disrupting the PI3K/AKT/mTOR pathway, indirectly affecting Bpifa6. Suppresses PI3K and mTOR activities, leading to downstream changes in gene expression that indirectly modulate Bpifa6 levels by influencing the PI3K/AKT/mTOR pathway. | ||||||